PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts.
Saved in:
| Title: | PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts. |
|---|---|
| Authors: | Jenkins E; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK.; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Fellermeyer M; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK.; Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK., Heraghty DF; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Sharma S; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Mitra T; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.; Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK., Kotowski M; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Clarke J; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Lui Y; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Daly S; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Marin Z; Max Perutz Labs, Vienna Biocenter Campus, Vienna, Austria.; Department of Structural and Computational Biology, University of Vienna, Vienna, Austria., Banik D; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Körbel M; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Ng EZQ; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Lister T; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Santos AM; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Lee SF; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Dustin ML; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.; Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK., Davis SJ; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Medical Research Council Translational Immune Discovery Unit, University of Oxford, Oxford, UK., Klenerman D; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK. |
| Source: | Science immunology [Sci Immunol] 2026 May 15; Vol. 11 (119), pp. eadz4983. Date of Electronic Publication: 2026 May 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
